The lower eyelid was everted, and the MGs were viewed using the Oculus Keratograph 5M (Oculus, Wetzlar, Germany). One shortened gland and one full-length gland were marked (
Fig. 1A) on the lower lid using a surgical pen (Livingston surgical marker [LIVSKMRN: NSW, Australia]). The choice of either the left or right eye was made based on the presence of both a short and long gland in the same eye for each participant. Short and long glands that were adjacent to each other were not considered for meibum collection. Samples for all participants were collected at approximately the same time of day, by the same investigator to avoid diurnal variations.
19 A micro-capillary tube (Drummond Microcap 100 µL, Drummond Scientific Company, Broomall, PA, USA) was placed vertically on the face of the orifice
20 and each marked gland was expressed using a Korb expressor (Tear Science, Australia;
Fig. 1B) placed below the eyelash line of the lower eyelid for 10 seconds
21 to ensure the expressed meibum was from the marked glands. In addition, all the sample collection was conducted by the same investigator. Meibum from the same marked gland was collected at two time points under a slit lamp biomicroscope (Carl Zeiss Pty Ltd, New South Wales, Australia), approximately 2.5 hours apart, as the recovery time of MGs after expression is approximately 2 hours for healthy subjects.
22 The aim was to collect approximately 1 mm of meibum measured in the microcapillary tube, with an expected range of 0.25 mm to 1.5 mm.
20
Lid margins were not cleaned before collection as cleaning the lid margin was not found to affect the composition of lipids expressed from the glands.
23 In all cases during meibum collection, the eyelid was gently turned away from the eye to reduce contamination by tears.
24 The meibum sample was dissolved in 300 µL chloroform in a glass vial and stored at −80°C until analysis.
21